Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 15, 2020.
Article Versions
- You are currently viewing a Latest version of this article (September 15, 2020 - 04:00).
- latest version (February 15, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- John K. Botson,
- John R.P. Tesser,
- Ralph Bennett,
- Howard M. Kenney,
- Paul M. Peloso,
- Katie Obermeyer,
- Brian LaMoreaux,
- Michael E. Weinblatt and
- Jeff Peterson
- Orthopedic Physicians Alaska, Anchorage, AK; Arizona Arthritis & Rheumatology Associates, P.C., Phoenix, AZ; Arizona Arthritis & Rheumatology Associates, P.C., Phoenix, AZ; Arthritis Northwest, PLLC, Spokane, WA; Horizon Therapeutics, Lake Forest, IL; Horizon Therapeutics, Lake Forest, IL; Brigham and Women’s Hospital, Boston, MA; Western Washington Arthritis Clinic, Bothell, WA.
Conflict of interest: Dr. Botson has received research support from Horizon Therapeutics and Radius Health as a study site and principal investigator. He has received consulting/speaker fees >10k from Horizon Therapeutics, Celgene, Novartis, and AbbVie. Dr. Tesser has received research grants/support from Horizon. Dr. Bennett has no financial relationships that pose a potential conflict of interest. Dr. Kenney has received research support from Horizon Therapeutics as a study site and principal investigator. He has also served as a speaker for Horizon Therapeutics. Dr. Peloso, Ms. Obermeyer, and Dr. LaMoreaux are employees of and own stock in Horizon Therapeutics. Dr. Weinblatt has received grants from Amgen, Bristol-Myers Squibb, Crescendo Bioscience, Lilly and Sanofi. He has received consulting fees >10k from Bristol Myers Squibb, Corona, and Lilly and <10k from AbbVie, Amgen, Arena, GlaxoSmithKline, Gilead Sciences, Horizon Therapeutics, Lycera, Novartis, Pfizer, Roche, Samsung, Scipher Medicine, and Set Point; he has stock options in Lycera, Can-Fite BioPharma, Scipher Medicine, Inmedix, and Vorso. Dr. Peterson has received research support from Horizon Therapeutics (study site/investigator). He has also served as an advisor and speaker for Horizon Therapeutics.
Corresponding Author: John K. Botson, MD, RPh, Orthopedic Physicians Alaska, 3801 Lake Otis Parkway, Anchorage, AK 99508. jbotson@opaak.com